Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02777372 · ClinicalTrials.gov registry record · Phase 4
Stress & Premenstrual Symptoms Study
A Phase 4 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 4
- Development phase
- 84
- Enrollment target
NCT02777372: Completed Phase 4 study, sponsored by Johns Hopkins University.
NCT02777372 is a Phase 4 study that has completed, run by Johns Hopkins University. The registered enrollment target is 84 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02777372, a Phase 4 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 84 participants
- Enrollment target
Study Summary
This study that aims to evaluate the psychophysiology of premenstrual mood disorders (PMDs) at baseline and after treatment with sertraline. Participants will include women with PMDs and healthy female controls. Participation involves a baseline visit to determine eligibility and three study visits that include questionnaires and stress reactivity assessment via an acoustic startle paradigm. Female participants with PMDs will receive sertraline during the premenstrual phase.
Interventions
- DRUG Sertraline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2016-04-01 |
| Est. Completion | 2021-12-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02777372
The ClinicalTrials.gov registry entry for NCT02777372 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sertraline is the first listed.
NCT02777372 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02777372 about?
NCT02777372 is a clinical study titled "Stress & Premenstrual Symptoms Study". This study that aims to evaluate the psychophysiology of premenstrual mood disorders (PMDs) at baseline and after treatment with sertraline. Participants will include women with PMDs and healthy female controls. Participation involves a baseline visit to determine eligibility and three study visits ...
What is the current status of trial NCT02777372?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 84 participants. The study started on 2016-04-01. Estimated completion is 2021-12-01.
What interventions are being tested in trial NCT02777372?
The interventions under investigation include: Sertraline (DRUG).
Who is sponsoring clinical trial NCT02777372?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.